ArticleJournal of imaging2026
3D Deep Learning for Brain Tumor Segmentation and Survival Prediction: A Comprehensive Multi-Modal Analysis Using the BraTS2020 Dataset.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThree-dimensional deep learning offers promise for automated accurate brain tumor segmentation and survival prediction but requires robust validation across multiple MRI modalities to be effectively implemented in clinical practice.
methodsThis study presents a comprehensive 3D deep learning framework using 369 cases from the BraTS2020 dataset. A 3D U-Net architecture was developed for tumor segmentation utilizing combined imaging data and optimized for computational efficiency and memory. The final 3D U-Net model segmentations were used to build machine learning 6-month and 12-month survival classifiers. Segmentation models were evaluated using multiple metrics, including the Dice Similarity Coefficient, Hausdorff Distance, and Cohen's d. The classification models were evaluated using AUC-ROC and balanced accuracy.
resultsSegmentation achieved a modest, but promising, performance across 30 epochs and with 295 training patients, achieving the best mean validation Dice = 0.8388 and a final-epoch mean Dice of 0.8263. Survival classification with a hybrid clinical and imaging logistic regression showed promising results, with 12-month prediction achieving AUC = 0.746 and 69% accuracy. The top contributing features for the 12-month prediction classifier were extent of resection, T1 contrast-enhanced tumor median, and FLAIR tumor median.
conclusionsThis comprehensive framework demonstrates that a multi-modal approach provides meaningful performance gains, while segmentation-derived features show a promising ability to enable survival prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.